December 4, 2018 Chromatography M&A, Partnerships

PhyNexus, Inc. Enters Into An Agreement To Be Acquired By Biotage AB

SAN JOSE, Calif., Dec. 4, 2018 /PRNewswire/ — PhyNexus, Inc., a privately held California corporation, announces today an agreement to be acquired by Biotage AB (Nasdaq Stockholm: BIOT.ST), strengthening its position for world-wide sales and marketing of automated lab-scale purification technology of biomolecules. Together, PhyNexus and Biotage will be able to provide their global customers an enabling automation platform... Read more

December 4, 2018 Clinical Research/Diagn. M&A, Partnerships

The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors

Zurich, Switzerland and Dortmund, Germany – 4 December 2018 – The European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors. Glioblastoma is the most... Read more

December 4, 2018 Clinical Research/Diagn. M&A, Partnerships

Cofactor Genomics to Provide Solid Tumor Immune Profiling for Genocea Biosciences

— Pilot study to evaluate use of Cofactor assay in Genocea’s neoantigen vaccine clinical trial —December 04, 2018 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s ImmunoPrismTM assay in Genocea Biosciences’ Phase 1/2a clinical trial testing the... Read more

December 3, 2018 Environ, Ag./Food & Bev Informatics & Software Life Science Tools M&A, Partnerships

NRGene Announces Expanded Licensing Agreement with Bayer for the GenoMAGIC Platform

Following successful evaluation, Bayer has chosen the GenoMAGICTM platform to support its advanced molecular breeding program in several key crops Ness Ziona, Israel – (December 3, 2018) –NRGene, the worldwide leader in genomic analysis, announces a key milestone in its multi-year licensing agreement with Bayer for the use of GenoMAGICTM, a cloud-based big data analytics platform... Read more

December 1, 2018 Lab Top-10 M&A, Partnerships

Merck KGaA, Darmstadt, Germany, successfully divests Consumer Health

01 DEC 2018 | DARMSTADT, GERMANY Closing of sale to Procter & Gamble at a cash purchase price of € 3.4 billion completed Successful completion allows Merck KGaA, Darmstadt, Germany, to further focus on innovation driven businesses in Healthcare, Life Science and Performance Materials Transaction successfully closed within an ambitious timeframe  Merck KGaA, Darmstadt, Germany, a leading science and... Read more

November 29, 2018 Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Valens expands research collaboration with Thermo Fisher Scientific

KELOWNA, BC, Nov. 29, 2018 /PRNewswire/ – Valens GroWorks Corp. (CSE: VGW,OTC: MYMSF) (the “Company” or “Valens“), a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce it has established an expanded research collaboration agreement with Thermo Fisher Scientific.... Read more

November 29, 2018 Atomic Spectroscopy Industrial M&A, Partnerships

Rigaku to partner with Covalent Metrology to deliver New Semiconductor Lab Resources in Silicon Valley

A new collaboration between Rigaku and Covalent will deliver state-of-the-art metrology capabilities to the semiconductor and electronics markets November 29, 2018 – Sunnyvale, CA. Rigaku Corporation, a global leader in X-ray analytical instrumentation, is pleased to announce a new partnership with Covalent Metrology, a leading provider of analytical services to advanced materials innovation companies. In a... Read more

November 27, 2018 M&A, Partnerships

AMETEK Acquires Spectro Scientific

BERWYN, Pa., Nov. 27, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Spectro Scientific, a leading provider of machine condition monitoring solutions for critical assets in high-value industrial applications. Spectro provides both lab-based and onsite instrumentation, consumables and cloud-based software analytics to help customers determine and monitor the... Read more